Posted On: 12/30/2013 10:19:23 AM
Post# of 144784
$CNDO Recent News
Restoration Hardware shares fall on co-CEO resigning 6:07 p.m. Dec. 12, 2013 - Wallace Witkowski
Coronado Biosciences up 22% on autism study data 5:16 p.m. Dec. 12, 2013 - Wallace Witkowski
What insiders are buying these days 4:52 p.m. July 25, 2013 - Insider Monkey
3 new bets by a biotech hedge fund 3:56 a.m. July 10, 2012 - The Trading Deck
Coronado prices offering at 6.7% discount 11:35 a.m. June 22, 2012 - MarketWatch.com
Strength Seen in Coronado Biosciences (CNDO): Stock Soars 26.7% - Tale of the Tape 9:04 a.m. Dec. 27, 2013 - Zacks.com
Update on Coronado's TSO - Analyst Blog 4:45 p.m. Dec. 16, 2013 - Zacks.com
Monday’s Biggest Stock Losers: USU, TMUS, and More 5:19 a.m. Dec. 16, 2013 - InvestorPlace.com
Two Biopharmaceutical Companies Moving Markets on Friday 12:42 p.m. Dec. 13, 2013 - TheStreet.com
Coronado Biosciences +12.4% AH on interim CNDO-201 study 5:00 p.m. Dec. 12, 2013 - Seeking Alpha
Coronado Releases Interim Data; Says Final Results of Study Expected Mid 2014 3:34 p.m. Dec. 12, 2013 - benzinga.com
UPDATE: Coronado Biosciences Presents Interim Data from Autism Study at Neuropsychopharmacology Meeting 3:33 p.m. Dec. 12, 2013 - benzinga.com
Can The Uptrend Continue for Coronado Biosciences Inc. (CNDO)? - Tale of the Tape 7:47 a.m. Dec. 11, 2013 - Zacks.com
Coronado Biosciences (CNDO) Jumps: Stock Adds 13.4% in Session - Tale of the Tape 8:51 a.m. Dec. 10, 2013 - Zacks.com
The Big Picture At Unilife 11:28 a.m. Dec. 9, 2013 - Seeking Alpha
Coronado Biosciences Inc. Enters Oversold Territory - Tale of the Tape 9:05 a.m. Nov. 29, 2013 - Zacks.com
The '5 Dumbest Things' Holiday Quiz: Answers 6:30 a.m. Nov. 29, 2013 - TheStreet.com
The 5 Dumbest Things on Wall Street Holiday Quiz 6:30 a.m. Nov. 22, 2013 - TheStreet.com
Coronado Biosciences Announces Independent Data Monitoring Committee Recommends Discontinuing Falk Phase 2 Trial of TSO in Crohn's Disease 5:38 a.m. Nov. 7, 2013 - benzinga.com
10-Q: CORONADO BIOSCIENCES INC 5:10 p.m. Nov. 1, 2013 - Edgar Online - (EDG = 10Q, 10K)
Pricey, Volatile Biotech Stocks Losing Favor 9:55 a.m. Oct. 25, 2013 - WSJ.com
First Week Of CNDO December 21st Options Trading 12:44 p.m. Oct. 23, 2013 - TheStreet.com
Tripling Your Money: The Long And Short Of It 9:05 p.m. Oct. 20, 2013 - Seeking Alpha
The 5 Dumbest Things on Wall Street This Week: Oct. 18 7:00 a.m. Oct. 18, 2013 - TheStreet.com
Coronado Biosciences Inc. Enters Oversold Territory - Tale of the Tape 5:20 a.m. Oct. 17, 2013 - Zacks.com
Coronado Biosciences Announces Management Changes 7:00 a.m. Dec. 20, 2013 - GlobeNewswire
Healthcare Companies Report Interim Data, Clinical Study Results, and Announcements - Research Report on Pfizer, Coronado Biosciences, Spectranetics, Celsion, and Intercept 8:00 a.m. Dec. 18, 2013 - PR Newswire
Coronado Biosciences Announces Presentation of Interim Data From Autism Study at Neuropsychopharmacology Meeting 4:30 p.m. Dec. 12, 2013 - GlobeNewswire
Coronado Biosciences Announces IND Submission for TSO for the Treatment of Moderate to Severe Chronic Plaque Psoriasis 8:01 a.m. Dec. 9, 2013 - GlobeNewswire
TrendingWallStreet.com Releases Unusual Volume Alerts on IO, OSGIQ, AAMRQ, and CNDO 12:20 a.m. Nov. 8, 2013 - ACCESSWIRE
Coronado Biosciences Announces Independent Data Monitoring Committee Recommendation to Discontinue Falk Phase 2 Trial of TSO in Crohn's Disease 6:30 a.m. Nov. 7, 2013 - GlobeNewswire
Coronado Biosciences Announces Personnel Realignment, Including Appointment of Kevin Horgan, M.D., as Chief Medical Officer 6:30 a.m. Nov. 6, 2013 - GlobeNewswire
Coronado Biosciences Reports Financial Results for the Third Quarter Ended September 30, 2013 7:00 a.m. Nov. 1, 2013 - GlobeNewswire
TSLA, ARIA, CNDO and AMRN added to NASDAQ Active Stock Watch List at EPR 8:15 a.m. Oct. 15, 2013 - ACCESSWIRE
Coronado Biosciences Announces Top-Line Results From Its TRUST-I Phase 2 Clinical Trial of TSO for the Treatment of Crohn's Disease 7:30 a.m. Oct. 14, 2013 - GlobeNewswire
Record Use of At-the-Market (ATM) Offerings by U.S. Life Sciences Companies in First Half of 2013, Reports Brinson Patrick 7:00 a.m. Sept. 17, 2013 - PR Newswire
Coronado Biosciences Announces Initiation of Phase 2 Study Evaluating TSO in Ulcerative Colitis 6:30 a.m. Sept. 12, 2013 - GlobeNewswire
Coronado Biosciences to Present at Upcoming Healthcare Investor Conferences 7:30 a.m. Sept. 3, 2013 - GlobeNewswire
Coronado Biosciences to Participate in Citi's 8th Annual Biotech Conference 7:30 a.m. Aug. 27, 2013 - GlobeNewswire
Coronado Biosciences to Present at the Upcoming Themes in Helminth Biology Scientific Conference 7:30 a.m. Aug. 20, 2013 - GlobeNewswire
Five Star Equities Issues New Research Reports on CNDO, INO, NTE and TDS 8:01 a.m. Aug. 6, 2013 - ACCESSWIRE
Coronado Biosciences Reports Financial Results for the Second Quarter Ended June 30, 2013 6:00 a.m. Aug. 5, 2013 - GlobeNewswire
Coronado Biosciences to Present at Upcoming Healthcare Investor Conferences 7:30 a.m. Aug. 1, 2013 - GlobeNewswire
Coronado Biosciences to Report Second Quarter 2013 Financial Results 7:00 a.m. July 25, 2013 - GlobeNewswire
Q&A With Coronado Biosciences CEO Harlan Weisman, M.D. 6:01 a.m. July 23, 2013 - Marketwire
Restoration Hardware shares fall on co-CEO resigning 6:07 p.m. Dec. 12, 2013 - Wallace Witkowski
Coronado Biosciences up 22% on autism study data 5:16 p.m. Dec. 12, 2013 - Wallace Witkowski
What insiders are buying these days 4:52 p.m. July 25, 2013 - Insider Monkey
3 new bets by a biotech hedge fund 3:56 a.m. July 10, 2012 - The Trading Deck
Coronado prices offering at 6.7% discount 11:35 a.m. June 22, 2012 - MarketWatch.com
Strength Seen in Coronado Biosciences (CNDO): Stock Soars 26.7% - Tale of the Tape 9:04 a.m. Dec. 27, 2013 - Zacks.com
Update on Coronado's TSO - Analyst Blog 4:45 p.m. Dec. 16, 2013 - Zacks.com
Monday’s Biggest Stock Losers: USU, TMUS, and More 5:19 a.m. Dec. 16, 2013 - InvestorPlace.com
Two Biopharmaceutical Companies Moving Markets on Friday 12:42 p.m. Dec. 13, 2013 - TheStreet.com
Coronado Biosciences +12.4% AH on interim CNDO-201 study 5:00 p.m. Dec. 12, 2013 - Seeking Alpha
Coronado Releases Interim Data; Says Final Results of Study Expected Mid 2014 3:34 p.m. Dec. 12, 2013 - benzinga.com
UPDATE: Coronado Biosciences Presents Interim Data from Autism Study at Neuropsychopharmacology Meeting 3:33 p.m. Dec. 12, 2013 - benzinga.com
Can The Uptrend Continue for Coronado Biosciences Inc. (CNDO)? - Tale of the Tape 7:47 a.m. Dec. 11, 2013 - Zacks.com
Coronado Biosciences (CNDO) Jumps: Stock Adds 13.4% in Session - Tale of the Tape 8:51 a.m. Dec. 10, 2013 - Zacks.com
The Big Picture At Unilife 11:28 a.m. Dec. 9, 2013 - Seeking Alpha
Coronado Biosciences Inc. Enters Oversold Territory - Tale of the Tape 9:05 a.m. Nov. 29, 2013 - Zacks.com
The '5 Dumbest Things' Holiday Quiz: Answers 6:30 a.m. Nov. 29, 2013 - TheStreet.com
The 5 Dumbest Things on Wall Street Holiday Quiz 6:30 a.m. Nov. 22, 2013 - TheStreet.com
Coronado Biosciences Announces Independent Data Monitoring Committee Recommends Discontinuing Falk Phase 2 Trial of TSO in Crohn's Disease 5:38 a.m. Nov. 7, 2013 - benzinga.com
10-Q: CORONADO BIOSCIENCES INC 5:10 p.m. Nov. 1, 2013 - Edgar Online - (EDG = 10Q, 10K)
Pricey, Volatile Biotech Stocks Losing Favor 9:55 a.m. Oct. 25, 2013 - WSJ.com
First Week Of CNDO December 21st Options Trading 12:44 p.m. Oct. 23, 2013 - TheStreet.com
Tripling Your Money: The Long And Short Of It 9:05 p.m. Oct. 20, 2013 - Seeking Alpha
The 5 Dumbest Things on Wall Street This Week: Oct. 18 7:00 a.m. Oct. 18, 2013 - TheStreet.com
Coronado Biosciences Inc. Enters Oversold Territory - Tale of the Tape 5:20 a.m. Oct. 17, 2013 - Zacks.com
Coronado Biosciences Announces Management Changes 7:00 a.m. Dec. 20, 2013 - GlobeNewswire
Healthcare Companies Report Interim Data, Clinical Study Results, and Announcements - Research Report on Pfizer, Coronado Biosciences, Spectranetics, Celsion, and Intercept 8:00 a.m. Dec. 18, 2013 - PR Newswire
Coronado Biosciences Announces Presentation of Interim Data From Autism Study at Neuropsychopharmacology Meeting 4:30 p.m. Dec. 12, 2013 - GlobeNewswire
Coronado Biosciences Announces IND Submission for TSO for the Treatment of Moderate to Severe Chronic Plaque Psoriasis 8:01 a.m. Dec. 9, 2013 - GlobeNewswire
TrendingWallStreet.com Releases Unusual Volume Alerts on IO, OSGIQ, AAMRQ, and CNDO 12:20 a.m. Nov. 8, 2013 - ACCESSWIRE
Coronado Biosciences Announces Independent Data Monitoring Committee Recommendation to Discontinue Falk Phase 2 Trial of TSO in Crohn's Disease 6:30 a.m. Nov. 7, 2013 - GlobeNewswire
Coronado Biosciences Announces Personnel Realignment, Including Appointment of Kevin Horgan, M.D., as Chief Medical Officer 6:30 a.m. Nov. 6, 2013 - GlobeNewswire
Coronado Biosciences Reports Financial Results for the Third Quarter Ended September 30, 2013 7:00 a.m. Nov. 1, 2013 - GlobeNewswire
TSLA, ARIA, CNDO and AMRN added to NASDAQ Active Stock Watch List at EPR 8:15 a.m. Oct. 15, 2013 - ACCESSWIRE
Coronado Biosciences Announces Top-Line Results From Its TRUST-I Phase 2 Clinical Trial of TSO for the Treatment of Crohn's Disease 7:30 a.m. Oct. 14, 2013 - GlobeNewswire
Record Use of At-the-Market (ATM) Offerings by U.S. Life Sciences Companies in First Half of 2013, Reports Brinson Patrick 7:00 a.m. Sept. 17, 2013 - PR Newswire
Coronado Biosciences Announces Initiation of Phase 2 Study Evaluating TSO in Ulcerative Colitis 6:30 a.m. Sept. 12, 2013 - GlobeNewswire
Coronado Biosciences to Present at Upcoming Healthcare Investor Conferences 7:30 a.m. Sept. 3, 2013 - GlobeNewswire
Coronado Biosciences to Participate in Citi's 8th Annual Biotech Conference 7:30 a.m. Aug. 27, 2013 - GlobeNewswire
Coronado Biosciences to Present at the Upcoming Themes in Helminth Biology Scientific Conference 7:30 a.m. Aug. 20, 2013 - GlobeNewswire
Five Star Equities Issues New Research Reports on CNDO, INO, NTE and TDS 8:01 a.m. Aug. 6, 2013 - ACCESSWIRE
Coronado Biosciences Reports Financial Results for the Second Quarter Ended June 30, 2013 6:00 a.m. Aug. 5, 2013 - GlobeNewswire
Coronado Biosciences to Present at Upcoming Healthcare Investor Conferences 7:30 a.m. Aug. 1, 2013 - GlobeNewswire
Coronado Biosciences to Report Second Quarter 2013 Financial Results 7:00 a.m. July 25, 2013 - GlobeNewswire
Q&A With Coronado Biosciences CEO Harlan Weisman, M.D. 6:01 a.m. July 23, 2013 - Marketwire
(0)
(0)Scroll down for more posts ▼
